feed,title,long_url,short_url
SeekingAlpha,"AstraZeneca FY21 revenue rises 41% Y/Y; FY22: growth in Evusheld, decline in Vaxzevria",https://seekingalpha.com/news/3798377,
SeekingAlpha,"Will traders let fly, or magnify their outcry, to today's CPI?",https://seekingalpha.com/news/3798378,
